Novel sphingolipids from Conyza canadensis.
New sphingolipids, 1,3,5-trihydroxy-2-hexadecanoylamino-(6E,9E)-heptacosdiene (1). 1,3,5-trihydroxy-2-hexadecanoylamino-(6E,9E)-heptacosdiene-1-O-glucopyranoside (2). 1,3-dihydroxy-2-hexanoylamino-(4E)-heptadecene (3). have been isolated from Conyza canadensis, along with five known compounds, p-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 3,5-dimethoxybenzoic acid, 3beta-hydroxyolean-12-en-28-oic acid, and 3beta-erythrodiol, isolated for the first time from this species. Their structures were determined by spectroscopic methods ((1)H- and (13)C-NMR, IR and MS) and two dimensional (2D)-NMR experiments.[1]References
- Novel sphingolipids from Conyza canadensis. Mukhtar, N., Iqbal, K., Malik, A. Chem. Pharm. Bull. (2002) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg